1. Home
  2. NAMS vs ASO Comparison

NAMS vs ASO Comparison

Compare NAMS & ASO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NAMS
  • ASO
  • Stock Information
  • Founded
  • NAMS 2019
  • ASO 1938
  • Country
  • NAMS Netherlands
  • ASO United States
  • Employees
  • NAMS N/A
  • ASO N/A
  • Industry
  • NAMS Biotechnology: Pharmaceutical Preparations
  • ASO Recreational Games/Products/Toys
  • Sector
  • NAMS Health Care
  • ASO Consumer Discretionary
  • Exchange
  • NAMS Nasdaq
  • ASO Nasdaq
  • Market Cap
  • NAMS 3.1B
  • ASO 3.3B
  • IPO Year
  • NAMS N/A
  • ASO 2020
  • Fundamental
  • Price
  • NAMS $38.74
  • ASO $46.73
  • Analyst Decision
  • NAMS Strong Buy
  • ASO Buy
  • Analyst Count
  • NAMS 10
  • ASO 17
  • Target Price
  • NAMS $43.70
  • ASO $57.65
  • AVG Volume (30 Days)
  • NAMS 1.3M
  • ASO 1.7M
  • Earning Date
  • NAMS 11-06-2025
  • ASO 12-09-2025
  • Dividend Yield
  • NAMS N/A
  • ASO 1.11%
  • EPS Growth
  • NAMS N/A
  • ASO N/A
  • EPS
  • NAMS N/A
  • ASO 5.32
  • Revenue
  • NAMS $64,006,000.00
  • ASO $5,971,497,000.00
  • Revenue This Year
  • NAMS N/A
  • ASO $4.02
  • Revenue Next Year
  • NAMS N/A
  • ASO $6.32
  • P/E Ratio
  • NAMS N/A
  • ASO $8.80
  • Revenue Growth
  • NAMS 762.15
  • ASO N/A
  • 52 Week Low
  • NAMS $14.06
  • ASO $33.34
  • 52 Week High
  • NAMS $41.47
  • ASO $61.25
  • Technical
  • Relative Strength Index (RSI)
  • NAMS 66.43
  • ASO 38.34
  • Support Level
  • NAMS $35.50
  • ASO $47.79
  • Resistance Level
  • NAMS $39.03
  • ASO $51.55
  • Average True Range (ATR)
  • NAMS 2.30
  • ASO 1.98
  • MACD
  • NAMS -0.16
  • ASO -0.56
  • Stochastic Oscillator
  • NAMS 61.67
  • ASO 6.13

About NAMS NewAmsterdam Pharma Company N.V.

NewAmsterdam Pharma Co NV is a late-stage biopharmaceutical company with a mission to improve patient care in populations with metabolic diseases where currently approved therapies have not been adequate or well tolerated. Its product, obicetrapib, is a next-generation, oral, low-dose CETP inhibitor that is developed to potentially overcome the limitations of current LDL-C lowering treatments.

About ASO Academy Sports and Outdoors Inc.

Academy Sports and Outdoors Inc is engaged in the full-line sporting goods and outdoor recreation retailer in the United States. The company's product categories are outdoors, apparel, sports & recreation, and footwear.

Share on Social Networks: